Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

global access

Ariad’s lung cancer drug impresses at ESMO

Early stage trials demonstrate potential in hard-to-treat patients

Roche - Basel

Roche’s T-DM1 activity in breast cancer “outstanding”

Improves survival by six months compared to GSK’s Tykerb/Tyverb

- PMLiVE

AZ share buyback suspension prompts M&A speculation

Analysts query new CEO Pascal Soriot’s intention to preserve cash reserves

- PMLiVE

RCGP unveils draft Social Media Highway Code for doctors

Offers UK healthcare professionals 10 guiding principles to follow

European approvals for J&J cancer treatments

EC passes new Dacogen indications and backs subcutaneous Velcade

- PMLiVE

Sanofi promotes diabetes expert Paul Chew to chief medical officer

Takes over from Jean-Pierre Lehner who retires

Frances Heller joins BMS senior management

Takes up business development role and will report to Lamberto Andreotti

A new dogma in HTA assessment

New communication routes to HTA agencies are needed to ensure that these organisations can advise on clinical trial design

- PMLiVE

Novo drops late-stage haemophilia candidate vatreptacog alfa

Patients developed anti-drug antibodies during phase III clinical trial

- PMLiVE

AZ launches science blog LabTalk

Hopes new blog will build relationships with potential collaborators

- PMLiVE

Bayer gets US green light for colorectal cancer drug Stivarga

Follows FDA approval for Sanofi and Regeneron's Zaltrap in same indication

- PMLiVE

Indian drug price cuts up for Cabinet approval

Aims to expand access to medicines in one of world’s fastest growing markets

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links